(Q49884608)

English

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.

scientific article published on 22 September 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

14

object named as

Masatoshi Kudo

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

Norihiro Kokudo

6

object named as

Norihiro Kokudo

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

3

object named as

Takashi Kumada

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

4

object named as

Namiki Izumi

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Michiie Sakamoto

10

object named as

Michiie Sakamoto

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

author name string

Atsushi Hiraoka

1

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Kojiro Michitaka

2

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Masumi Kadoya

5

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Shoji Kubo

7

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Yutaka Matsuyama

8

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Osamu Nakashima

9

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Tadatoshi Takayama

11

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Takashi Kokudo

12

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Kosuke Kashiwabara

13

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

publication date

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

6

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

4

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

325-336

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Prognostic significance of combined albumin-bilirubin and tumor-node-metastasis staging system in patients who underwent hepatic resection for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of he

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonazoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Percutaneous ethanol injection therapy for hepatocellular-carcinoma (review).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Assessment of liver function for safe hepatic resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Percutaneous ethanol injection therapy for liver tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Criteria for safe hepatic resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5704689

8 September 2018

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

1 reference

https://api.crossref.org/works/10.1159%2F000479984

21 January 2018

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

1 reference

https://api.crossref.org/works/10.1159%2F000479984

21 January 2018

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/29234636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography

1 reference

https://pubmed.ncbi.nlm.nih.gov/29234636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29234636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites

1 reference

https://pubmed.ncbi.nlm.nih.gov/29234636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/29234636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29234636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1159/000479984

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29234636

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49884608&oldid=1831959777"